Spruce Biosciences Common Stock Volatility Indicators Average True Range

SPRB Stock

USD 61.06 1.16 1.94%

Use the volatility indicators workspace to apply Average True Range indicator and other studies to Spruce Biosciences. The focus on volatility indicators and range-based signals helps organize trend, volatility, and risk context for Spruce Biosciences.Enter Time Period to start the analysis.

Symbol

The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Spruce Biosciences Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Spruce Biosciences Technical Analysis Modules

Most technical analysis of Spruce Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Spruce from various momentum indicators to cycle indicators. When you analyze Spruce charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people. As a micro-cap equity, Spruce Biosciences is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 12.48. Spruce Biosciences has a market cap of 68.7 M, ROE of -109.25%.

Methodology

Unless otherwise specified, financial data for Spruce Biosciences Common is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Spruce (USA Stocks:SPRB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Spruce Biosciences Common is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Spruce Biosciences inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Corona Opportunity Invested few shares	Go
	Baby Boomer Prospects Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Blockchain Invested few shares	Go
	Adviser Favorites Invested few shares	Go
	Artificial Intelligence Invested few shares	Go
	SRI Sustainable Growth Invested few shares	Go
	Data Storage Invested few shares	Go
	Impulse Invested over 200 shares	Go
	ESG Investing Invested few shares	Go
	Driverless Cars Invested few shares	Go

More Resources for Spruce Stock Analysis

Reviewing Spruce Biosciences Common commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Spruce Stock:

How To Invest In Spruce

Details

Is Spruce Stock a good investment?

Details

What is Spruce Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Spruce Biosciences has a market cap of 68.7 M, ROE of -109.25%. See World Market Map for portfolio-level analysis. This suggests a position in Spruce Biosciences Common within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Analysis related to Spruce Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Earnings Share

-84.32

Revenue Per Share

1.201

Quarterly Revenue Growth

-0.76

Return On Assets

-0.36

Return On Equity

-1.09

Investors evaluate Spruce Biosciences Common using market value and book value, each describing different facets of the business. Spruce Biosciences' market capitalization is 68.7 M. With a P/B ratio of 12.48, the market values Spruce Biosciences well above its book equity. Enterprise value stands at 59.38 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.

The concept of value for Spruce Biosciences differs from its quoted price, since each reflects a different lens. For Spruce Biosciences, key inputs include a P/B ratio of 12.48, ROE of -109.25%, and revenue of 697 K. Trading price represents the transaction level agreed by market participants.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Spruce Biosciences Common Stock Volatility Indicators Average True Range

Spruce Biosciences Technical Analysis Modules

Stock Overview, Methodology & Data Sources

Methodology

Analyst Sources

This content is curated and reviewed by:

Become your own money manager

Did you try this?

Run Transaction History Now

Transaction History

Trending Themes

More Resources for Spruce Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY